Suven Life Sciences Ltd
NSE:SUVEN

Watchlist Manager
Suven Life Sciences Ltd Logo
Suven Life Sciences Ltd
NSE:SUVEN
Watchlist
Price: 125 INR 0.68%
Market Cap: 27.3B INR
Have any thoughts about
Suven Life Sciences Ltd?
Write Note

Suven Life Sciences Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Suven Life Sciences Ltd
Total Liabilities & Equity Peer Comparison

Comparables:
DIVISLAB
DCAL
WINDLAS
SYNGENE
I
INNOVACAP

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Suven Life Sciences Ltd
NSE:SUVEN
Total Liabilities & Equity
â‚ą2.8B
CAGR 3-Years
30%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Divi's Laboratories Ltd
NSE:DIVISLAB
Total Liabilities & Equity
â‚ą154.7B
CAGR 3-Years
13%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Dishman Carbogen Amcis Ltd
NSE:DCAL
Total Liabilities & Equity
â‚ą95.8B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Windlas Biotech Ltd
NSE:WINDLAS
Total Liabilities & Equity
â‚ą6.3B
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Total Liabilities & Equity
â‚ą61.5B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
N/A
I
Innova Captab Ltd
NSE:INNOVACAP
Total Liabilities & Equity
â‚ą13.2B
CAGR 3-Years
53%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Suven Life Sciences Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
2.8B INR

Based on the financial report for Jun 30, 2024, Suven Life Sciences Ltd's Total Liabilities & Equity amounts to 2.8B INR.

What is Suven Life Sciences Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
-18%

Over the last year, the Total Liabilities & Equity growth was -27%. The average annual Total Liabilities & Equity growth rates for Suven Life Sciences Ltd have been 30% over the past three years , -18% over the past five years .

Back to Top